| Wagner CC, Locher P, Elke B, et al.
[In Process Citation] [Journal Article]
Praxis (Bern 1994) 2009 Oct 21; 98(21):1185-92.
Full Citation |
| Wargo KA, Banta WM
A Comprehensive Review of the Loop Diuretics: Should Furosemide Be First Line? (November)(CE). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Oct 20.
Abstract | Full Citation |
| Barbanoj MJ, Ballester MR, Antonijoan RM, et al.
A BIOAVAILABILITY/BIOEQUIVALENCE AND PHARMACOKINETIC STUDY OF TWO ORAL DOSES OF TORASEMIDE (5 AND 10 mg): PROLONGED-RELEASE VERSUS THE CONVENTIONAL FORMULATION. [JOURNAL ARTICLE]
Clin Exp Pharmacol Physiol 2009 May 1; 36(5-6):469-477.
Abstract | Full Citation | Find Related Articles |
| Díez J, Coca A, de Teresa E, et al.
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure. [Journal Article, Research Support, Non-U.S. Gov't]
Expert Rev Cardiovasc Ther 2009 Aug; 7(8):897-904.
Abstract | Full Citation |
| Lyseng-Williamson KA
Torasemide prolonged release. [Journal Article]
Drugs 2009; 69(10):1363-72.
Abstract | Full Citation | Find Related Articles |
| Tanaka H, Watanabe K, Harima M, et al.
Effects of various diuretics on cardiac function in rats with heart failure. [Journal Article]
Yakugaku Zasshi 2009 Jul; 129(7):871-9.
Abstract | Full Citation |
| Fiegler K, Liechti ME, Bodmer M, et al.
[Intoxication with lithium.] [English Abstract, Journal Article]
Praxis (Bern 1994) 2009 Jun 17; 98(13):685-91.
Abstract | Full Citation | Find Related Articles |
| Harada K, Izawa H, Nishizawa T, et al.
Beneficial Effects of Torasemide on Systolic Wall Stress and Sympathetic Nervous Activity in Asymptomatic or Mildly Symptomatic Patients With Heart Failure: Comparison With Azosemide. [JOURNAL ARTICLE]
J Cardiovasc Pharmacol 2009 Apr 25.
Abstract | Full Citation | Find Related Articles |
| Pitt B, Nicklas J
Loop Diuretics in Patients With Heart Failure: Time to Change to Torsemide? [JOURNAL ARTICLE]
J Cardiovasc Pharmacol 2009 Apr 25.
Full Citation | Find Related Articles |
| Rowland A, Knights KM, Mackenzie PI, et al.
Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): Potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters. [JOURNAL ARTICLE]
Drug Metab Dispos 2009 Apr 27.
Abstract | Full Citation | Find Related Articles |
  |
